France 2030 Budget: €54B ▲ Total allocation | Deployed: €35B+ ▲ 65% of total | Companies Funded: 4,200+ ▲ +800 in 2025 | Startups Funded: 850+ ▲ +150 in 2025 | Competitions: 150+ ▲ 12 currently open | Gigafactories: 15+ ▲ In construction | Jobs Created: 100K+ ▲ Direct employment | Battery Capacity: 120 GWh ▲ 2030 target | H2 Electrolyzers: 6.5 GW ▲ 2030 target | Nuclear SMRs: 6+ ▲ In development | Regions: 18 ▲ All covered | France 2030 Budget: €54B ▲ Total allocation | Deployed: €35B+ ▲ 65% of total | Companies Funded: 4,200+ ▲ +800 in 2025 | Startups Funded: 850+ ▲ +150 in 2025 | Competitions: 150+ ▲ 12 currently open | Gigafactories: 15+ ▲ In construction | Jobs Created: 100K+ ▲ Direct employment | Battery Capacity: 120 GWh ▲ 2030 target | H2 Electrolyzers: 6.5 GW ▲ 2030 target | Nuclear SMRs: 6+ ▲ In development | Regions: 18 ▲ All covered |

InnovaFeed — France 2030 Company Profile

InnovaFeed: France 2030 funding, projects, sector role, and strategic position in France's 54 billion euro plan.

InnovaFeed is France’s most successful insect protein company and one of the most compelling examples of France 2030’s ambition to transform the food and agriculture sector through industrial biology. Founded in 2016 by Cédric Carles, Alexis Eriksson, and Joël Barthel in Hauts-de-France, the company has built the world’s largest black soldier fly (BSF) insect protein facility — currently producing approximately 20,000 tonnes of protein per year from its flagship Gouzeaucourt site, with plans to scale dramatically through international expansion. With approximately €250 million raised through a Series D round backed by Temasek (Singapore’s sovereign wealth fund), ADM (Archer-Daniels-Midland, the US agribusiness giant), and other strategic investors, InnovaFeed has become a flagship of France’s third agricultural revolution agenda.

InnovaFeed’s core proposition is simple but industrially significant: black soldier fly larvae are extraordinarily efficient converters of organic waste streams into high-quality protein and lipids. The larvae consume agricultural byproducts — cereal co-products, sugar beet pulp, plant-based organic waste — and transform them into insect meal that can substitute for fishmeal and soy protein in aquaculture feed, poultry feed, and potentially pet food and human nutrition. This circularity is both the environmental rationale and the economic advantage: InnovaFeed pays very little for its feedstock (in some cases, producers pay InnovaFeed to take their waste), converting a cost center in the food industry into high-value protein.

France 2030 Funding & Projects

InnovaFeed is a direct beneficiary of France 2030’s food and agriculture pillar, which targets the emergence of alternative protein industries as part of France’s “third agricultural revolution” — a deliberate analogy to the mechanization and green revolution that transformed 20th-century farming. The company has received Bpifrance support through both equity co-investment programs and grants for industrial R&D, and has been recognized as a French Tech Next 40 company — one of the 40 fastest-growing French tech companies as designated by the French government.

The most distinctive feature of InnovaFeed’s industrial model — and its strongest claim to France 2030 alignment — is its industrial symbiosis structure. The Gouzeaucourt facility is co-located with a Tereos sugar production plant, which provides waste heat from its industrial processes to warm InnovaFeed’s larvae rearing halls. This is not a minor operational detail: insect rearing is highly temperature-sensitive, and waste heat from the adjacent sugar plant reduces InnovaFeed’s energy costs by an estimated 30-40% compared to a standalone facility, directly improving economics and reducing the carbon footprint of its protein production. This industrial symbiosis model is exactly what France 2030’s industrial decarbonization programs aim to catalyze: the elimination of waste through integrated industrial clusters.

The ADM partnership, announced as part of the Series D, goes beyond capital injection. ADM — one of the world’s largest grain handlers and agricultural processors — is InnovaFeed’s partner for US market development, providing access to feedstock supply chains, agricultural customer relationships, and the regulatory navigation experience needed to enter the US animal feed market. This positions InnovaFeed’s Gouzeaucourt facility as a technology template to be replicated in ADM’s North American industrial footprint.

Technology & Innovation

InnovaFeed’s technological moat is its industrial-scale mastery of the black soldier fly value chain — from egg production and larvae rearing through harvesting, processing, and ingredient formulation. BSF rearing at industrial scale requires precise control of temperature, humidity, CO2 levels, feeding regimes, and larval density across hundreds of thousands of square meters of production space. The company has developed proprietary automation, monitoring, and process control systems that allow it to operate at a consistency and scale that competitors have struggled to match.

The biological optimization work is equally significant. InnovaFeed’s R&D team has developed BSF strains with improved feed conversion ratios, faster growth rates, and optimized protein/lipid profiles for specific end-market applications (aquaculture requires a different amino acid profile than poultry feed, for instance). This genetic and husbandry optimization is ongoing, representing a compounding competitive advantage as the company’s biological intellectual property database grows with each production cycle.

The frass byproduct — the organic material remaining after larvae have processed their feedstock — has value as a soil amendment and biofertilizer. InnovaFeed has begun developing frass as a product line, adding a second revenue stream and further improving the circular economy credentials of its operation. This positions the company at the center of a circular bioeconomy: organic waste in, protein + fertilizer out.

Competitive Landscape

The global insect protein industry is consolidating rapidly. InnovaFeed’s primary competitors include Ÿnsect (a French competitor focused on mealworms rather than BSF, which raised over €400 million but has faced commercial challenges), Protix (Netherlands, BSF specialist, partnered with Cargill), Innovafeed (UK), and Enterra Feed (Canada). In Asia, where insect farming has traditional agricultural roots, numerous Chinese and Southeast Asian producers are scaling BSF production without the same capital requirements as European competitors.

InnovaFeed’s competitive advantages over European peers are the Gouzeaucourt scale (the largest single BSF facility globally), the industrial symbiosis model (which structurally reduces costs), and the ADM partnership (which provides a credible path to North American scale). The key risk is that cheaper Asian production eventually commoditizes insect meal, squeezing margins for high-cost European producers — although food safety requirements, traceability standards, and customer preference for European supply chains provide some protection.

Investor Perspective

InnovaFeed represents a high-growth bet on the alternative protein sector reaching commercial maturity on a 5-10 year horizon. The investment thesis combines several powerful trends: global aquaculture growth driving demand for non-fishmeal protein sources, tightening EU regulations on soy imports (linked to deforestation concerns), and food industry sustainability commitments that favor circular economy ingredients.

The Series D valuation and the caliber of investors (Temasek is one of Asia’s most sophisticated sovereign investors; ADM understands agribusiness economics intimately) signal that InnovaFeed has de-risked its industrial model sufficiently to attract capital that demands commercial, not just strategic, returns. The path to profitability involves scaling production to the point where fixed cost amortization per tonne drops below the selling price of competing protein sources — a volume game that the ADM partnership is designed to accelerate.

Key risks: BSF production is not infinitely scalable (land, regulatory permits, and feedstock availability all constrain geographic expansion), and the regulatory environment for insect protein in human food remains uncertain in the EU. The company’s focus on animal feed, where regulatory pathways are clearer, is the prudent commercial choice.

  • Ÿnsect — French mealworm protein competitor
  • Tereos — Waste heat industrial symbiosis partner at Gouzeaucourt
  • ADM — US expansion and strategic investor
  • Sanofi — France 2030 health innovation ecosystem context